- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Melanoma in United Kingdom
Total 4605 results
-
American Regent, Inc.Completed
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
National Human Genome Research Institute (NHGRI)Completed
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Memorial Sloan Kettering Cancer CenterYale University; University of New MexicoCompleted
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted
-
NeoPlas InnovationWithdrawnMelanoma | Malignant MelanomaUnited States
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Mt. Sinai Medical Center, MiamiBayer; Celgene CorporationCompletedMalignant MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8United States
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
Power Life Sciences Inc.Not yet recruitingStage IV MelanomaUnited States
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Lynn E. Spitler, MDUniversity of California, San FranciscoCompletedMalignant Melanoma, MetastaticUnited States
-
Genzyme, a Sanofi CompanyUnknownMelanoma (Skin)United States
-
Baylor Research InstituteTerminatedMalignant Melanoma Stage IVUnited States
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
Saint John's Cancer InstituteTerminatedMetastatic MelanomaUnited States
-
DermTechCompleted
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstitutePfizer; University of California, San FranciscoCompleted
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Northern California Melanoma CenterBayer; Melanoma Research InstituteCompleted
-
Titan PharmaceuticalsTerminated
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI)RecruitingMetastatic MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCutaneous MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
National Cancer Institute (NCI)Fox Chase Cancer CenterCompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin MelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Maria WeiCompleted
-
University of UtahCompletedMelanoma (Skin)United States
-
SciBase ABCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedMelanoma (Skin)United States
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Melanoma | Triple-Negative Breast CancerUnited States
-
iOncturaActive, not recruitingMyelofibrosis | NSCLC | Uveal Melanoma | Solid Tumor, Adult | Non-Hodgkin Lymphoma, AdultUnited Kingdom, Italy
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
VicalCompletedMetastatic MelanomaUnited States
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)France, Spain, United Kingdom, Belgium, Australia, Poland, Germany, Netherlands, Slovenia, Italy, Switzerland, Israel, Bulgaria, Croatia, Czech Republic, Estonia, Portugal, Turkey